BIBLIOGRAPHIC RECORD

Regulatory Considerations Specific to Liposome Drug Development as Complex Drug Products

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Yuwei Wang; David W. Grainger
Source of metadata
Crossref
Year recorded
2022

Public identifiers and source

Open the source record

Reference

Yuwei Wang; David W. Grainger. (2022). Regulatory Considerations Specific to Liposome Drug Development as Complex Drug Products. https://doi.org/10.3389/fddev.2022.901281

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-8d2d464cdbded52723e812b88ebe3dc1/